ELI LILLY & CoLLY
What ELI LILLY & Co does.
Eli Lilly and Company (referred to as the company, Lilly, we, or us) was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. We discover, develop, manufacture, and market products in a single business segment—human pharmaceutical products.
Our purpose is to unite caring with discovery to create medicines that make life better for people around the world. Our long-term success depends on our ability to continually discover or acquire, develop, and commercialize innovative medicines.
We manufacture and distribute our products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. Our products are sold in approximately 90 countries.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $24.5B | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| Net income | $6.2B | $5.6B | $6.2B | $5.2B | $10.6B | $20.6B |
| Free cash flow | $5.1B | $6.1B | $5.7B | $792.0M | $3.8B | $9.0B |
More on LLY.
- ELI LILLY & Co summary
- ELI LILLY & Co financial statements
- ELI LILLY & Co key metrics
- ELI LILLY & Co health scores and style box
- ELI LILLY & Co earnings
- ELI LILLY & Co dividends
- ELI LILLY & Co valuation
- ELI LILLY & Co ownership and insiders
- ELI LILLY & Co peers
Figures from ELI LILLY & Co's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.